Avalon GloboCare Corp. Financial Summary

Quick Answer

Avalon GloboCare Corp. reported Total Revenue of $1.33 million for fiscal year 2024.

Avalon GloboCare Corp. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $1.33M
+6.2%
$1.26M
+4.5%
$1.20M
-13.6%
$1.39M
+1.0%
$1.38M
-10.9%
Net Income $94.5K
+101.2%
-$7.90M
+52.7%
-$16.71M
-40.0%
-$11.93M
-31.2%
-$9.09M
+28.3%
-$12.68M
+29.8%
Diluted EPS -$5.64
+33.2%
-$8.44
+64.5%
-$23.80
-1759.4%
-$1.28
-19.6%
-$1.07
Total Assets $23.40M
+11.5%
$20.99M
+2.0%
$20.58M
+4.2%
$19.75M
+92.8%
$10.24M
-1.2%
$10.37M
-1.2%
Cash and Equivalents $285.4K
-85.7%
$1.99M
+146.5%
$807.5K
+11.1%
$726.6K
-5.0%
Stockholders Equity $9.23M
+30.0%
$7.10M
-3.6%
$7.37M
-34.0%
$11.16M
+261.8%
$3.08M
-25.1%
$4.12M
-28.4%
R&D Expense $109.6K
-85.0%
$731.3K
-28.7%
$1.03M
+16.0%
$883.9K
-50.4%
Operating Income -$7.59M
-56.8%
-$4.84M
+69.3%
-$15.75M
-79.2%
-$8.79M
+0.5%
-$8.83M
+29.1%
-$12.45M
+35.7%
Gross Profit $272.7K
-34.2%
$414.5K
+6.2%
$390.2K
+14.8%
Shares Outstanding 1.45M
+0.2%
1.44M
+96.7%
733,302
-92.6%
9.96M
+12.6%
8.85M
-89.2%
82.28M
+8.0%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $350.1K +1.4% -0.1%
Net Income September 30, 2025 -$254.3K +84.9% +98.1%
Diluted EPS September 30, 2025 -$0.06 +96.7% +99.0%
Total Assets September 30, 2025 $9.13M -53.3% +14.3%
Cash and Equivalents June 30, 2024 $200.6K -34.3%
Stockholders Equity September 30, 2025 -$4.49M -183.2% +36.8%
R&D Expense June 30, 2023 $17.8K -93.0% -80.7%
Operating Income September 30, 2025 -$76.2K +94.0% +98.0%
Gross Profit September 30, 2022 $70.2K -58.4% -11.2%
Shares Outstanding September 30, 2025 4.10M +274.4% +74.4%
  • Avalon GloboCare Corp. reported Total Revenue of $1.33 million for fiscal year 2024.
  • Avalon GloboCare Corp. showed an increase of +6.2% in Total Revenue compared to the prior fiscal year.
  • Avalon GloboCare Corp. reported Net Income of -$18.26 million for fiscal year 2025.
  • Avalon GloboCare Corp. showed a decrease of -19433.4% in Net Income compared to the prior fiscal year.
  • Avalon GloboCare Corp. reported Diluted EPS of $5.64 per share (loss) for fiscal year 2025.
  • Avalon GloboCare Corp. showed an increase of +33.2% in Diluted EPS compared to the prior fiscal year.
  • Avalon GloboCare Corp. reported Total Assets of $23.40 million for fiscal year 2025.
  • Avalon GloboCare Corp. showed an increase of +11.5% in Total Assets compared to the prior fiscal year.
  • Avalon GloboCare Corp. reported Cash and Equivalents of $285.4 thousand for fiscal year 2023.
  • Avalon GloboCare Corp. showed a decrease of -85.7% in Cash and Equivalents compared to the prior fiscal year.
  • Avalon GloboCare Corp. reported Stockholders Equity of $9.23 million for fiscal year 2025.
  • Avalon GloboCare Corp. showed an increase of +30.0% in Stockholders Equity compared to the prior fiscal year.
  • Avalon GloboCare Corp. reported R&D Expense of $109.6 thousand for fiscal year 2023.
  • Avalon GloboCare Corp. showed a decrease of -85.0% in R&D Expense compared to the prior fiscal year.
  • Avalon GloboCare Corp. reported Operating Income of -$7.59 million for fiscal year 2025.
  • Avalon GloboCare Corp. showed a decrease of -56.8% in Operating Income compared to the prior fiscal year.
  • Avalon GloboCare Corp. reported Gross Profit of $272.7 thousand for fiscal year 2022.
  • Avalon GloboCare Corp. showed a decrease of -34.2% in Gross Profit compared to the prior fiscal year.
  • Avalon GloboCare Corp. reported Shares Outstanding of 1.45 million shares for fiscal year 2025.
  • Avalon GloboCare Corp. showed an increase of +0.2% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment